Amgen (AMGN)

Add to Watchlists
Create an Alert
99.19 -2.31  -2.28%   NASDAQ Jun 19, 5:00PM BATS Real time Currency in USD

Amgen Return on Equity:

23.79% for March 31, 2013
View Full Chart

Amgen Return on Equity Chart

    Amgen Historical Return on Equity Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 23.79%
    Dec. 31, 2012 22.61%
    Sept. 30, 2012 22.32%
    June 30, 2012 18.05%
    March 31, 2012 16.70%
    Dec. 31, 2011 15.72%
    Sept. 30, 2011 15.43%
    June 30, 2011 18.69%
    March 31, 2011 19.34%
    Dec. 31, 2010 19.91%
    Sept. 30, 2010 19.70%
    June 30, 2010 20.85%
    March 31, 2010 21.76%
    Dec. 31, 2009 21.47%
    Sept. 30, 2009 21.51%
    June 30, 2009 21.30%
    March 31, 2009 20.12%
    Dec. 31, 2008 21.17%
    Sept. 30, 2008 22.07%
    June 30, 2008 17.52%
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Return on Equity (ROE)

    Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

    ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

    Investors generally are interested in company's that have high, increasing returns on equity.
    Learn More

    Get data for

    AMGN Return on Equity Benchmarks

    Companies
    Celgene Corporation 24.81%
    Pfizer 19.04%
    Gilead Sciences 33.10%

    AMGN Return on Equity Rankings

    Overall 95th percentile
    727 of 16782
    Sector 96th percentile
    51 of 1410 in Healthcare
    Industry 96th percentile
    16 of 454 in Biotechnology

    AMGN Return on Equity Range, Past 5 Years

    Minimum 15.43% Sep 2011
    Maximum 23.79% Mar 2013
    Average 20.00%

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');